Oppenheimer Asset Management Inc. Bio Rad Laboratories, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $7.62 Billion
- Q2 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 2,719 shares of BIO stock, worth $931,583. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,719
Previous 2,273
19.62%
Holding current value
$931,583
Previous $786,000
5.6%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding BIO
# of Institutions
461Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$814 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$531 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$387 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$295 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$226 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.44B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...